Related Experiment Video

Updated: Feb 25, 2026

Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics
11:02

Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics

Published on: November 29, 2024

1.4K

Metabolomics and Cardiology: Toward the Path of Perinatal Programming and Personalized Medicine

Roberta Pintus1, Pier Paolo Bassareo2, Angelica Dessì1

  • 1Department of Surgery, Neonatal Intensive Care Unit, Neonatal Pathology and Neonatal Section, University of Cagliari, Policlinico Universitario, Strada Statale 554, Km 4.500, Bivio di Sestu, Monserrato, 09042 Cagliari, Italy.

Biomed Research International
|August 1, 2017
PubMed

Insights

Metabolomics offers a promising approach to detect early signs of heart disease by analyzing metabolic shifts. This can lead to earlier diagnosis, improved patient quality of life, and reduced mortality rates.

Area of Science:

  • Biochemistry
  • Cardiology
  • Systems Biology

Background:

  • Heart disease is a leading cause of death and chronic illness in Western countries, imposing significant healthcare costs.
  • There is a critical need for novel technologies to effectively treat and prevent cardiac conditions.
  • Metabolomics provides a snapshot of an individual's metabolic state under various conditions.

Purpose of the Study:

  • To review recent literature on metabolomics applications in cardiology.
  • To identify early predictive biomarkers for heart disease by understanding pre-manifestation metabolic shifts.
  • To explore how metabolomics can improve patient outcomes and reduce mortality.

Main Methods:

  • Literature review of recent studies on metabolomics in cardiology.
  • Analysis of metabolic shifts associated with cardiovascular pathologies.
  • Identification of potential early diagnostic and predictive biomarkers.

Main Results:

  • Metabolomics can reveal metabolic alterations preceding the clinical manifestation of heart diseases.
  • Early identification of these metabolic shifts may enable timely intervention.
  • The technology holds potential for developing personalized medicine approaches in cardiology.

Conclusions:

  • Metabolomics is a promising tool for early detection and prevention of heart disease.
  • Identifying metabolic biomarkers can lead to improved patient quality of life and reduced mortality.
  • Advancements in metabolomics support the development of tailored medical treatments for cardiac patients.

More Related Videos

Author Spotlight: Multi-Layered Approach to Understand Postnatal Functions of Pancreatic Islets in Non-Human Primates03:39

Author Spotlight: Multi-Layered Approach to Understand Postnatal Functions of Pancreatic Islets in Non-Human Primates

Published on: November 8, 2024

830
Stable Isotope In-Vivo Labeling for Mass-Spectrometry Identification of Paternal Metabolites Transferred from Sperm to Oocyte During Fertilization05:55

Stable Isotope In-Vivo Labeling for Mass-Spectrometry Identification of Paternal Metabolites Transferred from Sperm to Oocyte During Fertilization

Published on: June 17, 2025

909

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
49
Pharmacogenetics and Pharmacogenomics: Overview01:29

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
70
Pharmacogenetics of Drug Metabolism: Overview01:27

Pharmacogenetics of Drug Metabolism: Overview

Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
67
Regulation of Metabolism01:19

Regulation of Metabolism

Cellular needs and conditions vary from cell to cell and change within individual cells over time. For example, the required enzymes and energetic demands of stomach cells are different from those of fat storage cells, skin cells, blood cells, and nerve cells. Furthermore, a digestive cell works much harder to process and break down nutrients during the time that closely follows a meal compared with many hours after a meal. As these cellular demands and conditions vary, so do the amounts and...
11.9K
Animal Mitochondrial Genetics02:59

Animal Mitochondrial Genetics

Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
9.6K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
979